Stock listing
BOATS:SIBN SI-BONE, Inc. Stock
US listing (BOATS) of SI-BONE, Inc. · home listing NASDAQ:SIBN
Follow SI-BONE, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:SIBN
$23.73 USD +0.19 (+0.8%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SIBN
- Day range
- $23.53 – $24.40 USDNov 20, 2026
- Volume
- 801,083 sharesNov 20, 2026
- Market cap
- $1.07B USDAt the close on Nov 20, 2026 · price × 45.11M shares outstanding
- 52-week range
- $11.48 – $25.92 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $15.00M USDMedian day 599,993 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:SIBN · Home | $23.73 USD | +0.19 (+0.8%) | 801,083 | $23.55 | $24.40 | $23.53 | $23.54 | Close on Nov 20, 2026 |
| Frankfurt:2K3 | €17.51 EUR | +0.017 (+0.1%) | — | €17.51 | €17.51 | €17.51 | €17.49 | Close on Nov 5, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SIBN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $23.73 | +0.19 | +0.8% | $23.55 | $24.40 | $23.53 | 801,083 | |
| $23.54 | +0.38 | +1.6% | $23.16 | $23.73 | $22.72 | 1,120,107 | |
| $23.16 | -0.25 | -1.1% | $23.21 | $23.46 | $22.94 | 875,917 | |
| $23.41 | -0.03 | -0.1% | $23.37 | $23.67 | $23.09 | 599,993 | |
| $23.44 | -0.70 | -2.9% | $24.40 | $24.68 | $23.40 | 443,690 | |
| $24.14 | -0.80 | -3.2% | $24.88 | $25.07 | $24.00 | 744,278 | |
| $24.94 | -0.16 | -0.6% | $25.10 | $25.47 | $24.72 | 547,414 | |
| $25.10 | -0.50 | -2.0% | $25.47 | $25.70 | $24.85 | 745,273 | |
| $25.60 | +1.36 | +5.6% | $24.21 | $25.74 | $23.39 | 1,438,673 | |
| $24.24 | -0.03 | -0.1% | $23.67 | $24.53 | $23.55 | 683,472 | |
| $24.27 | -0.68 | -2.7% | $24.95 | $25.02 | $23.66 | 924,943 | |
| $24.95 | +1.18 | +5.0% | $24.00 | $25.92 | $23.88 | 2,186,968 | |
| $23.77 | +3.55 | +17.6% | $19.50 | $23.93 | $19.07 | 3,299,126 | |
| $20.22 | -1.01 | -4.8% | $21.57 | $21.99 | $20.19 | 1,371,807 | |
| $21.23 | -1.18 | -5.3% | $22.25 | $22.25 | $20.95 | 1,249,188 | |
| $22.41 | +0.58 | +2.7% | $22.00 | $22.95 | $21.83 | 950,295 | |
| $21.83 | +0.39 | +1.8% | $21.32 | $21.96 | $21.32 | 452,492 | |
| $21.44 | +0.13 | +0.6% | $21.40 | $21.63 | $21.11 | 482,177 | |
| $21.31 | -0.17 | -0.8% | $21.41 | $21.56 | $20.70 | 361,058 | |
| $21.48 | -0.08 | -0.4% | $21.21 | $21.63 | $20.67 | 469,089 | |
| $21.56 | +0.74 | +3.6% | $20.93 | $21.73 | $20.93 | 527,759 | |
| $20.82 | +0.28 | +1.4% | $20.35 | $21.22 | $20.28 | 812,807 | |
| $20.54 | +0.88 | +4.5% | $19.90 | $20.59 | $19.85 | 640,804 | |
| $19.66 | -0.02 | -0.1% | $19.38 | $19.92 | $19.38 | 338,147 | |
| $19.68 | -0.23 | -1.2% | $19.91 | $20.02 | $19.19 | 1,165,695 | |
| $19.91 | +0.44 | +2.3% | $19.51 | $20.05 | $19.51 | 467,244 | |
| $19.47 | -0.21 | -1.1% | $19.62 | $19.87 | $19.42 | 407,810 | |
| $19.68 | -0.42 | -2.1% | $20.19 | $20.26 | $19.66 | 442,588 | |
| $20.10 | +0.73 | +3.8% | $19.40 | $20.11 | $19.36 | 553,694 | |
| $19.37 | +0.51 | +2.7% | $18.90 | $19.44 | $18.90 | 555,920 | |
| $18.86 | -0.24 | -1.3% | $18.98 | $19.12 | $18.42 | 762,773 | |
| $19.10 | -0.45 | -2.3% | $19.27 | $19.69 | $18.98 | 547,632 | |
| $19.55 | -0.26 | -1.3% | $19.92 | $20.00 | $19.21 | 538,733 | |
| $19.81 | +1.73 | +9.6% | $18.26 | $19.84 | $18.26 | 632,024 | |
| $18.08 | -0.33 | -1.8% | $18.60 | $18.80 | $17.95 | 547,322 | |
| $18.41 | -0.39 | -2.1% | $18.87 | $19.04 | $18.27 | 652,987 | |
| $18.80 | -0.35 | -1.8% | $19.15 | $19.27 | $18.80 | 640,213 | |
| $19.15 | +0.39 | +2.1% | $18.92 | $19.60 | $18.61 | 624,172 | |
| $18.76 | +0.17 | +0.9% | $18.59 | $18.82 | $18.40 | 461,559 | |
| $18.59 | +0.07 | +0.4% | $18.44 | $18.76 | $18.29 | 625,836 | |
| $18.52 | -0.08 | -0.4% | $18.60 | $18.77 | $18.29 | 630,209 | |
| $18.60 | -0.21 | -1.1% | $18.76 | $18.81 | $18.15 | 514,723 | |
| $18.81 | +0.36 | +2.0% | $18.63 | $18.87 | $18.59 | 450,106 | |
| $18.45 | +0.36 | +2.0% | $18.19 | $18.55 | $17.82 | 771,146 | |
| $18.09 | +0.05 | +0.3% | $17.87 | $18.41 | $17.82 | 861,414 | |
| $18.04 | -0.50 | -2.7% | $18.81 | $18.86 | $17.95 | 595,338 | |
| $18.54 | -0.01 | -0.1% | $18.50 | $18.79 | $18.35 | 411,380 | |
| $18.55 | -0.15 | -0.8% | $18.65 | $18.94 | $18.48 | 429,405 | |
| $18.70 | +0.32 | +1.7% | $18.54 | $18.80 | $18.30 | 550,964 | |
| $18.38 | +0.08 | +0.4% | $18.65 | $19.16 | $18.21 | 590,905 | |
| $18.30 | -0.11 | -0.6% | $18.45 | $18.69 | $17.99 | 686,068 | |
| $18.41 | -0.21 | -1.1% | $18.82 | $18.88 | $18.33 | 437,520 | |
| $18.62 | +0.12 | +0.6% | $18.25 | $18.85 | $18.16 | 541,962 | |
| $18.50 | -0.14 | -0.8% | $18.50 | $18.75 | $18.20 | 389,532 | |
| $18.64 | -0.52 | -2.7% | $19.45 | $19.65 | $18.55 | 632,454 | |
| $19.16 | +0.24 | +1.3% | $18.92 | $19.72 | $18.92 | 786,847 | |
| $18.92 | -0.10 | -0.5% | $19.12 | $19.46 | $18.62 | 561,078 | |
| $19.02 | -0.19 | -1.0% | $19.01 | $19.17 | $18.81 | 301,886 | |
| $19.21 | +0.01 | +0.1% | $19.38 | $19.61 | $19.14 | 361,127 | |
| $19.20 | -0.23 | -1.2% | $19.40 | $19.68 | $19.17 | 629,381 | |
| $19.43 | -0.11 | -0.6% | $19.50 | $19.95 | $19.24 | 601,112 | |
| $19.54 | +0.07 | +0.4% | $19.48 | $19.70 | $19.30 | 557,775 | |
| $19.47 | -0.49 | -2.5% | $20.00 | $20.30 | $19.42 | 699,828 | |
| $19.96 | +0.48 | +2.5% | $19.47 | $20.05 | $19.27 | 1,290,834 | |
| $19.48 | -0.43 | -2.2% | $19.66 | $19.75 | $19.11 | 518,038 |
- Ticker
- BOATS:SIBN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
SI-BONE To Present at Piper Sandler 38th Annual Healthcare Conference on December 1, 2026
Latest earnings call · Nov 2, 2026
SI-BONE (NASDAQ:SIBN) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Aug 3, 2026
Q2 2026 Earnings Presentation
Earnings · 27 slides
Latest news
SI-BONE To Present at Piper Sandler 38th Annual Healthcare Conference on December 1, 2026
Nov 19, 2026
Closed $23.73 (+0.8%) on Nov 20, 2026
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue Guidance
Nov 2, 2026
Closed $23.77 (+17.6%) on Nov 3, 2026
SI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026
Oct 29, 2026
Closed $21.23 (-5.3%) on Oct 30, 2026
SI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026
Oct 19, 2026
Closed $20.54 (+4.5%) on Oct 20, 2026
SI-BONE Receives FDA 510(k) Clearance for iFuse Granite Onyx™, Extending Its Compromised Bone Franchise Beyond the Pelvis
Sep 28, 2026
Closed $19.15 (+2.1%) on Sep 29, 2026
SI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026
Aug 31, 2026
Closed $18.92 (-0.5%) on Sep 1, 2026
Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
Aug 4, 2026
Closed $18.04 (-2.2%) on Aug 5, 2026
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance
Aug 3, 2026
Closed $18.44 (-0.1%) on Aug 4, 2026
SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026
Jul 20, 2026
Closed $17.04 (-0.5%) on Jul 21, 2026
SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026
Jun 4, 2026
Closed $14.88 (+6.9%) on Jun 4, 2026
SI-BONE, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 18 in the last 12 months · 145 in all · newest Nov 19, 2026 · oldest 2019
- Calls
- 25 calls with a replay · 25 with a transcript · latest Nov 2, 2026
- Decks
- 8 decks · latest Aug 3, 2026
Where SI-BONE, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:SIBN · Home listing | NASDAQ | United States | USD |
| LS Exchange:A2N7LY | LS Exchange | Germany | EUR |
| BOATS:SIBN · This page | BOATS | United States | USD |
| gettex:2K3 | gettex | Germany | EUR |
| Dusseldorf:2K3 | Dusseldorf | Germany | EUR |
| Frankfurt:2K3 | Frankfurt | Germany | EUR |
| Lang & Schwarz:A2N7LY | Lang & Schwarz | Germany | EUR |
| Munich:2K3 | Munich | Germany | EUR |
| Stuttgart:2K3 | Stuttgart | Germany | EUR |
| Tradegate:2K3 | Tradegate | Germany | EUR |
Valuation
EV/sales 4.8× against a median of 3.9×: 8th lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $1.07B USD
- P/E
- Loss
- EV/sales
- 4.8×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 5.8×
- Gross margin
- 79.4%
- Operating margin
- −7.6%
- Net margin
- −6.2%
- Debt to equity
- 0.2×
- Beta vs S&P 500
- 0.62
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| SI-BONE, Inc. · NASDAQ:SIBN | US$1.07B | US$1.07B | n/a | 4.8× | n/a | 5.8× | −6.2% | 0.2× | 0.62 |
| Eyebright Medical Technology (Beijing) Co., Ltd. Class A · SSE:688050 | US$1.18B | US$1.21B | 32.6× | 4.5× | n/a | 2.6× | 13.5% | 0.3× | n/a |
| Shandong Weigao Orthopaedic Device Co., Ltd. Class A · SSE:688161 | US$1.09B | US$897.1M | 30.3× | 4.3× | n/a | 1.7× | 17.2% | 0.0× | n/a |
| CeriBell, Inc. · NASDAQ:CBLL | US$1.06B | US$967.9M | n/a | 8.9× | n/a | 9.1× | −68.0% | 0.2× | 0.82 |
| CLASSYS Inc. · KRX:214150 | US$1.06B | US$959.3M | 10.3× | 3.5× | 7.0× | 2.6× | 37.3% | 0.0× | n/a |
| Shinva Medical Instrument Co. Ltd. Class A · SSE:600587 | US$1.04B | US$608.1M | 15.3× | 0.4× | n/a | 0.9× | 4.5% | 0.0× | n/a |
| Alphatec Holdings, Inc. · NASDAQ:ATEC | US$1.04B | US$1.51B | n/a | 1.8× | 31.6× | n/a | −10.3% | n/a | 1.26 |
| iRadimed Corporation · NASDAQ:IRMD | US$1.04B | US$972.8M | 43.2× | 10.9× | 31.9× | 9.7× | 26.9% | 0.0× | 0.65 |
| Integra LifeSciences Holdings Corporation · NASDAQ:IART | US$1.03B | US$1.42B | 79.2× | 0.8× | n/a | 1.0× | 0.8% | 0.7× | 1.47 |
| Draegerwerk AG & Co. KGaA · XETR:DRW8 | US$985.7M | US$911.1M | 5.3× | 0.2× | 2.0× | 0.5× | 4.7% | 0.1× | n/a |
| Shenzhen Edge Medical Co., Ltd. Class H · HKEX:2675 | US$973.0M | US$695.3M | n/a | 10.2× | n/a | 2.8× | −19.4% | 0.0× | n/a |
| Median of the others | US$1.04B | US$963.6M | 30.3× | 3.9× | 19.3× | 2.6× | 4.6% | 0.0× | 1.04 |
Forecasts
6 strong buy · 3 buy · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.
- Price target
- 26.44 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.34 · 7 analysts
- Revenue, year to Dec 2026
- 232.1M · 9 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Laura A. Francis | Chief Executive Officer |
| Mark Reiley | Founder |
Board
| Director | Role |
|---|---|
| Jeffrey W. Dunn | Chairman of the Board |
| Jeryl Lynn Hilleman | Director |
| John G. Freund | Director |
| Laura A. Francis | Chief Executive Officer |
| Mika Nishimura | Director |
| Thomas A. West | Director |
| Timothy E. Davis | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| SI-BONE (NASDAQ:SIBN) Q3 2026 Earnings Call | Mon, Nov 02, 2026 · 4:30 PM ET | Replay |
| SI-BONE (NASDAQ:SIBN) Q2 2026 Earnings Call | Mon, Aug 03, 2026 · 4:30 PM ET | Replay |
| SI-BONE (NASDAQ:SIBN) Q1 2026 Earnings Call | Mon, May 11, 2026 · 4:30 PM ET | Replay |
| SI-BONE (NASDAQ:SIBN) Q4 2025 Earnings Call | Mon, Feb 23, 2026 · 4:30 PM ET | Replay |
| SI-BONE (NASDAQ:SIBN) Q3 2025 Earnings Call | Mon, Nov 10, 2025 · 4:30 PM ET | Replay |
| SI-BONE (NASDAQ:SIBN) Q2 2025 Earnings Call | Mon, Aug 04, 2025 · 4:30 PM ET | Replay |
| SI-BONE (NASDAQ:SIBN) Q1 2025 Earnings Call | Mon, May 05, 2025 · 4:30 PM ET | Replay |
| SI-BONE (NASDAQ:SIBN) Q4 2024 Earnings Call | Mon, Feb 24, 2025 · 4:30 PM ET | Replay |
| SI-BONE (NASDAQ:SIBN) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 4:30 PM ET | Replay |
| SI-BONE (NASDAQ:SIBN) Q2 2024 Earnings Call | Mon, Aug 05, 2024 · 4:30 PM ET | Replay |
All 25 calls
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 2, 2026 · After close | +17.6% |
| Q2 2026 | Aug 3, 2026 · After close | −0.1% |
| Q1 2026 | May 11, 2026 · After close | +19.7% |
| Q4 2025 | Feb 23, 2026 · After close | −2.1% |
| Q3 2025 | Nov 10, 2025 · After close | +16.2% |
| Q2 2025 | Aug 4, 2025 · After close | −10.6% |
| Q1 2025 | May 5, 2025 · After close | +15.4% |
| Q4 2024 | Feb 24, 2025 · Before open | −2.1% |
| Q3 2024 | Nov 12, 2024 · After close | −15.9% |
| Q2 2024 | Aug 5, 2024 · After close | +1.3% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 6, 2024 · After close | +8.3% |
| Q4 2023 | Feb 26, 2024 · After close | −13.5% |
| Q3 2023 | Nov 6, 2023 · After close | −2.1% |
| Q2 2023 | Aug 7, 2023 · After close | −11.2% |
| Q1 2023 | May 1, 2023 · After close | +7.2% |
| Q4 2022 | Feb 27, 2023 · After close | +16.7% |
| Q3 2022 | Nov 7, 2022 · After close | −24.3% |
| Q2 2022 | Aug 8, 2022 · After close | −5.5% |
| Q1 2022 | May 9, 2022 · After close | −12.7% |
| Q4 2021 | Feb 28, 2022 · After close | −1.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2026 Earnings Presentation | Earnings | 27 slides | Aug 3, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 31 slides | Feb 23, 2026 |
| Investor Presentation (January 2026) | Investor deck | 26 slides | Jan 12, 2026 |
| Investor Presentation (January 2024) | Investor deck | 24 slides | Jan 8, 2024 |
| Investor Presentation (January 2023) | Investor deck | 25 slides | Jan 9, 2023 |
| Investor Presentation (January 2022) | Investor deck | 26 slides | Jan 10, 2022 |
| Investor Presentation (January 2021) | Investor deck | 28 slides | Jan 7, 2021 |
| Investor Presentation (January 2020) | Investor deck | 28 slides | Jan 9, 2020 |
IPO
Priced at US$15.00 a share on Oct 16, 2018.
- Price
- US$15.00 a share
- Shares offered
- 7,200,000 shares of common stock
- Offering size
- US$108 million
- Underwriters' option
- Up to 1,080,000 more shares
- Underwriters
- Morgan Stanley, BofA Merrill Lynch, Canaccord Genuity, JMP Securities · In the order on the cover
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 6, 2015 |
| Filed publicly | Sep 20, 2018 |
| Amended once | Oct 5, 2018 |
| Shares registered with an exchange | Oct 11, 2018 |
| Declared effective by the SEC | Oct 16, 2018 |
| Final prospectus, with the price | Oct 18, 2018 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Oct 18, 2018 |
| EFFECT · Notice that a registration is effective | Oct 16, 2018 |
| S-1MEF · Registration of more shares for the same offering | Oct 16, 2018 |
| CERT · Exchange's certificate of listing | Oct 15, 2018 |
| CORRESP · Letter to the SEC | Oct 15, 2018 |
| CORRESP · Letter to the SEC | Oct 15, 2018 |
| 8-A12B · Registration of shares for listing on an exchange | Oct 11, 2018 |
| S-1/A · Registration statement, amended | Oct 5, 2018 |
| CORRESP · Letter to the SEC | Sep 26, 2018 |
| CORRESP · Letter to the SEC | Sep 20, 2018 |
All 19 filings
| Filing | Filed |
|---|---|
| S-1 · Registration statement | Sep 20, 2018 |
| UPLOAD · Letter from the SEC | Aug 28, 2018 |
| DRS · Draft registration statement | Jul 31, 2018 |
| DRSLTR · Letter to the SEC with a draft | May 24, 2017 |
| DRS/A · Draft registration statement, amended | May 24, 2017 |
| UPLOAD · Letter from the SEC | Apr 21, 2017 |
| DRS · Draft registration statement | Mar 27, 2017 |
| DRS/A · Draft registration statement, amended | Nov 19, 2015 |
| DRS · Draft registration statement | Aug 6, 2015 |
Open IPO · From the cover of the final prospectus (424B4) filed Oct 18, 2018
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 200.9M | 167.2M | 138.9M | 106.4M | 90.2M | 73.4M | 67.3M | 55.4M | 48.0M |
| Cost of revenue | 41.0M | 35.1M | 29.5M | 15.7M | 10.4M | 8.90M | 6.79M | 4.83M | 5.11M |
| Gross profit | 159.9M | 132.1M | 109.4M | 90.7M | 79.7M | 64.5M | 60.5M | 50.5M | 42.9M |
| Research and development | 17.4M | 16.6M | 15.0M | 13.6M | 12.4M | 9.46M | 7.28M | 5.38M | 5.51M |
| Operating income | -22.3M | -35.2M | -46.9M | -59.6M | -51.7M | -38.6M | -36.0M | -12.0M | -17.4M |
| Depreciation and amortization | 5.77M | 4.38M | 5.43M | 3.45M | 2.09M | 1.13M | 774.0K | 722.0K | 1.01M |
| EBITDA | -16.6M | -30.9M | -41.5M | -56.2M | -49.6M | -37.4M | -35.2M | -11.2M | -16.3M |
| Interest expense | 2.63M | 3.44M | 3.46M | 2.82M | 5.37M | 6.10M | 4.95M | 5.11M | 6.20M |
| Income before tax | -19.1M | -31.1M | -43.5M | -61.4M | -57.0M | -43.7M | -38.4M | -17.5M | -23.0M |
| Income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Net income | -18.9M | -30.9M | -43.3M | -61.3M | -56.6M | -43.7M | -38.4M | -17.5M | -23.0M |
| Earnings per share, basic | -0.44 | -0.75 | -1.13 | -1.79 | -1.71 | -1.50 | -1.55 | -2.20 | -6.65 |
| Earnings per share, diluted | -0.44 | -0.75 | -1.13 | -1.79 | -1.71 | -1.50 | -1.55 | -2.20 | -6.65 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 42.2M | 34.9M | 33.3M | 20.7M | 63.4M | 53.6M | 10.4M | 25.1M | 22.4M |
| Short-term investments | 76.6M | 83.6M | 142.9M | 81.3M | 97.1M | ||||
| Receivables | 29.9M | 27.5M | 22.0M | 20.7M | 14.2M | 13.6M | 11.7M | 8.49M | 7.42M |
| Inventory | 33.9M | 27.1M | 20.2M | 17.3M | 11.5M | 5.63M | 5.45M | 3.34M | 2.55M |
| Current assets | 216.1M | 207.8M | 211.4M | 137.6M | 175.9M | 218.2M | 111.5M | 136.0M | 33.6M |
| Property, plant and equipment | 21.3M | 20.4M | 16.0M | 15.6M | 8.99M | 4.53M | 3.95M | 2.15M | 1.90M |
| Total assets | 238.6M | 230.4M | 230.4M | 157.6M | 190.5M | 223.1M | 117.0M | 138.5M | 35.8M |
| Accounts payable | 4.63M | 6.49M | 4.59M | 6.28M | 3.20M | 3.27M | 2.81M | 2.15M | 1.81M |
| Current liabilities | 25.3M | 27.1M | 23.5M | 21.2M | 16.9M | 13.5M | 18.8M | 9.01M | 7.54M |
| Long-term debt | 35.6M | 35.5M | 36.1M | 35.2M | 35.0M | 39.5M | 34.9M | 39.0M | 38.7M |
| Total debt | 35.6M | 35.5M | 36.1M | 35.2M | 35.0M | 39.5M | 39.2M | 39.0M | 38.7M |
| Total liabilities | 61.0M | 63.5M | 61.0M | 59.3M | 56.1M | 53.8M | 54.0M | 48.3M | 46.7M |
| Shareholders' equity | 177.5M | 167.0M | 169.4M | 98.3M | 134.4M | 169.4M | 63.0M | 90.2M | -129.4M |
| Shares outstanding | 43.6M | 42.1M | 40.7M | 34.7M | 33.7M | 32.6M | 25.2M | 24.5M | 3.60M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -675.0K | -12.4M | -18.7M | -41.7M | -39.5M | -30.7M | -31.6M | -14.5M | -17.5M |
| Capital spending | -8.41M | -10.5M | -7.80M | -9.51M | -6.39M | -2.56M | -2.44M | -942.0K | -478.0K |
| Free cash flow | -9.09M | -22.9M | -26.5M | -51.2M | -45.9M | -33.2M | -34.1M | -15.5M | -18.0M |
| Cash from investing | 4.16M | 12.6M | -59.8M | -2.81M | 51.6M | -62.9M | 13.5M | -97.8M | -478.0K |
| Cash from financing | 3.38M | 1.96M | 90.9M | 2.20M | -1.71M | 136.4M | 3.49M | 115.2M | 12.9M |
| Share buybacks | -38.0K | -73.0K | 0 | ||||||
| Change in cash | 7.29M | 1.68M | 12.6M | -42.7M | 9.84M | 43.1M | -14.7M | 2.71M | -5.49M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 17, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 13, 2026 | Big-stake notice | SEC |
| 4/A · Change in ownership, amended | Nov 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 4, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 144 · Notice of proposed sale | Nov 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 4, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 4, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 3, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Nov 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Nov 2, 2026 | Results | SEC |
| 144 · Notice of proposed sale | Oct 29, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Oct 29, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 14, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 13, 2026 | Other filings | SEC |
| 4 · Change in ownership | Oct 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Oct 5, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Oct 5, 2026 | Other filings | SEC |
| 8-K · Current report | Sep 11, 2026 | Material contract | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 26, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 26, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 24, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 24, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 21, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 21, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 21, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 20, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Aug 19, 2026 | Other filings | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 14, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 5, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 4, 2026 | Quarterly report | SEC |
| 144 · Notice of proposed sale | Aug 3, 2026 | Other filings | SEC |
| 8-K · Current report | Aug 3, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 30, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jul 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 8, 2026 | Material contract | SEC |
| 4 · Change in ownership | Jun 1, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 29, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 11, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 11, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 7, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | May 5, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 24, 2026 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Apr 21, 2026 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 21, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 21, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Apr 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Apr 3, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 13, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Mar 12, 2026 | Other filings | SEC |
| S-8 · Registration statement for employee plans | Feb 24, 2026 | Offer document | SEC |
| S-3ASR · Registration statement | Feb 24, 2026 | Offer document | SEC |
| 10-K · Annual report | Feb 24, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 23, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 18, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 12, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 12, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 12, 2026 | Results | SEC |
| 144 · Notice of proposed sale | Jan 8, 2026 | Other filings | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jan 2, 2026 | Other filings | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 11, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Dec 8, 2025 | Other filings | SEC |
| SCHEDULE 13G · Big-stake notice | Dec 5, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 26, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 25, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 21, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 21, 2025 | Other filings | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 19, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 18, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 13, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 12, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 10, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2025 | Results | SEC |
| 4 · Change in ownership | Nov 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Oct 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 12, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 11, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Aug 6, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 5, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 4, 2025 | Results | SEC |
| 4/A · Change in ownership, amended | Jul 22, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 7, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | Jul 7, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | Jul 3, 2025 | Other filings | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2025 | Insider trade | SEC |
| 8-K · Current report | Jun 6, 2025 | Meeting outcome | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 20, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 19, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 16, 2025 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | May 14, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 12, 2025 | Other filings | SEC |
| 4 · Change in ownership | May 9, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2025 | Insider trade | SEC |
| 144 · Notice of proposed sale | May 8, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 7, 2025 | Other filings | SEC |
| 144 · Notice of proposed sale | May 7, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | May 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2025 | Results | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| ARS · Annual report to shareholders | Apr 25, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 25, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 25, 2025 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 18, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 17, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Apr 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 4, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 4, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Mar 24, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Feb 25, 2025 | Offer document | SEC |
| 10-K · Annual report | Feb 25, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 13, 2025 | Results | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Nov 20, 2024 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 19, 2024 | Other filings | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 12, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2024 | Results | SEC |
This page holds 200 of 791 filings. Open Filings
Cap table
Built by 6ix from SI-BONE, Inc.’s releases · as of Oct 28, 2026
- Common shares
- 45,113,087
- Fully diluted
- 45,113,087
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 45,113,087 | Oct 28, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 28, 2026 | 45,113,087 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David Bonita Other companies: Windward Bio Group AG (Director · Since at least Nov 16, 2026); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); ImageneBio, Inc. (Director · Since at least Mar 25, 2021); Prelude Therapeutics Incorporated (Director · Since at least Mar 27, 2020); Acutus Medical Inc. (Director · Aug 5, 2020 – Jun 15, 2023 · Past); Repare Therapeutics Inc (Director · Jun 18, 2020 – Jun 17, 2024 · Past); Enliven Therapeutics, Inc. (Director · Mar 11, 2020 – Jun 2, 2022 · Past); Tricida Inc (Director · Jun 27, 2018 – Nov 22, 2022 · Past); Loxo Oncology Inc (Director · Jul 31, 2014 – Dec 8, 2017 · Past); Ambit Biosciences Corp (Director · May 15, 2013 – May 15, 2014 · Past) | Director · Oct 16, 2018 – Oct 19, 2018 · Past |
| John G. Freund Other companies: Collegium Pharmaceutical, Inc. (Director · Since at least May 6, 2015); Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Jun 6, 2024 · Past); Protara Therapeutics, Inc. (Director · Oct 21, 2014 – Nov 8, 2019 · Past); Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Feb 20, 2014 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Dec 10, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – May 29, 2007 · Past); Hansen Medical Inc (Director · Nov 15, 2006 – Jun 17, 2009 · Past); XenoPort Inc (Director · May 2, 2006 – Jul 5, 2016 · Past) | Director · Since at least Oct 16, 2018 |
| Jeryl Jeri Hilleman Other companies: Omada Health, Inc. (Director · Since at least Jun 5, 2025); NovoCure Limited (Director · Since at least Jun 8, 2022); Hillevax Inc (Director · Since at least Apr 28, 2022); Cutera Inc (Director · Jul 12, 2024 – Oct 24, 2024 · Past); Minerva Neurosciences, Inc (Director · Jun 10, 2022 – Sep 27, 2023 · Past) | Director · Since at least Jun 13, 2022 |
| Keith Valentine Other companies: Regentis Biomaterials Ltd. (Director · Since at least Mar 18, 2026); Alphatec Holdings, Inc. (Director · Since at least Jul 29, 2024); Orthofix Medical Inc. (President & CEO, Director · Jan 5, 2023 – Feb 28, 2023 · Past); SeaSpine Holdings Corp (Chief Executive Officer, Director · Jun 11, 2015 – Jan 5, 2023 · Past); NuVasive Inc (COO · Jan 3, 2006 – Jan 27, 2015 · Past) | Director · Oct 16, 2018 – Jun 9, 2023 · Past |
| Thomas A. West Other companies: CeriBell, Inc. (Director · Since at least Jul 28, 2026); Inogen, Inc (Director · Apr 1, 2023 – Jun 5, 2024 · Past); Orthofix Medical Inc. (Director · Dec 13, 2021 – Dec 31, 2022 · Past); Intersect ENT Inc (President and CEO, Director · Jul 22, 2019 – May 13, 2022 · Past); Hologic Inc (Div President & GM, Diagnostic · Oct 3, 2014 – Dec 1, 2018 · Past) | Director · Since at least Jun 25, 2024 |
| Gregory K Hinckley Other companies: Bio-Rad Laboratories, Inc. (Director · Since at least Apr 25, 2017); Super Micro Computer, Inc. (Director · Feb 8, 2011 – Feb 10, 2015 · Past); Mentor Graphics Corp (President · Sep 15, 2010 – Mar 30, 2017 · Past); Intermec Inc (Director · May 26, 2010 – Sep 17, 2013 · Past) | Director · Since at least Oct 16, 2018 |
| Heyward R Donigan Other companies: Rite Aid Corporation (President and CEO · Aug 12, 2019 – Aug 12, 2022 · Past); NxStage Medical Inc (Director · Jul 15, 2016 – Feb 21, 2019 · Past); Kindred Healthcare Inc (Director · Mar 26, 2014 – Jul 2, 2018 · Past) | Director · Jun 13, 2019 – Jun 13, 2019 · Past |
| Laura Francis Other companies: Bruker Corporation (Director · Since at least Feb 18, 2025); Shockwave Medical Inc (Director · Mar 6, 2019 – May 31, 2024 · Past) | Chief Executive Officer · Since at least Oct 16, 2018 |
| Mark J. Foley Other companies: Glaukos Corporation (Director · Since at least Dec 13, 2017); Revance Therapeutics, Inc. (President & CEO, Director · Nov 7, 2017 – Feb 4, 2025 · Past) | Director · Jun 13, 2019 – Jun 16, 2020 · Past |
| Joe Kostka Other companies: Bruker Corporation (Investor Relations · Since at least Dec 10, 2025) | Director, Investor Relations · Feb 21, 2025 – Nov 4, 2026 · Past |
All 27 people
| Person | Seat |
|---|---|
| Karen A Licitra Other companies: AngioDynamics, Inc. (Director · Since at least Jul 17, 2019) | Director · Oct 16, 2018 – Jun 25, 2021 · Past |
| Mika Nishimura Other companies: Accuray Incorporated (Director · Since at least Aug 17, 2021) | Director · Since at least Mar 4, 2021 |
| Timothy Petersen Other companies: Inogen, Inc (Director · Feb 12, 2014 – May 29, 2015 · Past) | Director · Oct 16, 2018 – Oct 19, 2018 · Past |
| Anshul Maheshwari | Chief Op & Financial Officer · Since at least May 16, 2022 |
| Anthony J Recupero | President, Commercial Ops · Since at least Oct 16, 2018 |
| ContactSaqib IqbalSr | Director, FP&A and Investor Relations · Jan 13, 2025 – Nov 4, 2026 · Past |
| Daniel W Wolf | Director · Since at least Aug 5, 2024 |
| Helen Loh | Director · Jun 16, 2022 – Jun 9, 2023 · Past |
| Jeffrey W. Dunn | Chairman of the Board · Since at least Oct 16, 2018 |
| Mark Reiley | Founder · Since at least Nov 4, 2026 |
| Michael A Pisetsky | Chief Legal Officer · Since at least Apr 18, 2022 |
| Saqib IqbalSr | Director, FP&A and Investor Relations · Feb 24, 2025 – Nov 4, 2026 · Past |
| Scott A Yerby | Chief Technology Officer · Oct 16, 2018 – Jan 15, 2020 · Past |
| Timothy E. Davis | Director · Since at least Jun 8, 2026 |
| Timothy E Davis Jr | Director · Since at least Oct 16, 2018 |
| Troy Wahlenmaier | Chief Commercial Officer · Aug 14, 2025 – Nov 4, 2026 · Past |
| W Carlton Reckling | CMO and VP, Medical Affairs · Oct 16, 2018 – Jan 15, 2020 · Past |
Log in to ask 6ix AI your own questions about SI-BONE, Inc.